GRRMF (Gerresheimer AG) EBIT: $156 Mil (TTM As of Aug. 2025)

Gerresheimer AG  (OTCPK:GRRMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gerresheimer AG's annualized ROC % for the quarter that ended in Aug. 2025 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Aug. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Gerresheimer AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2025 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Aug. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Gerresheimer AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG EBIT Related Terms

The historical data trend for Gerresheimer AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG EBIT Chart

Gerresheimer AG Annual Data
	Trend	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23	Nov24
EBIT		Get a 7-Day Free Trial					184.29	169.60	172.04	235.78	220.21

Gerresheimer AG Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25
EBIT	Get a 7-Day Free Trial															55.80	69.05	17.93	59.02	9.72

GRRMF vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gerresheimer AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's EV-to-EBIT falls into.

Gerresheimer AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $156 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Business Description